References
- Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021 May;71(3):209–249.
- Xu Y, Hosny A, Zeleznik R, et al. Deep learning predicts lung cancer treatment response from serial medical imaging. Clin Cancer Res. 2019 Jun 1;25(11):3266–3275.
- Smolle E, Pichler M. Non-smoking-associated lung cancer: a distinct entity in terms of tumor biology, patient characteristics and impact of hereditary cancer predisposition. Cancers (Basel). 2019 Feb 10;11(2):204.
- Guida F, Sun N, Bantis LE, et al. Assessment of lung cancer risk on the basis of a biomarker panel of circulating proteins. JAMA Oncol. 2018 Oct 1;4(10):e182078.
- Li F, Ding J. Sialylation is involved in cell fate decision during development, reprogramming and cancer progression. Protein Cell. 2019 Aug;10(8):550–565.
- Zhang R, Ma L, Li W, et al. Diagnostic value of multiple tumor-associated autoantibodies in lung cancer. Onco Targets Ther. 2019;12:457–469.
- Chen B, Huang S. Circular RNA: an emerging non-coding RNA as a regulator and biomarker in cancer. Cancer Lett. 2018 Apr 1;418:41–50.
- Wawrzyniak O, Zarębska Ż, Kuczyński K, et al. Protein-related circular RNAs in human pathologies. Cells. 2020 Aug 6;9(8):1841.
- Ma YS, Cao YF, Liu JB, et al. The power and the promise of circRNAs for cancer precision medicine with functional diagnostics and prognostic prediction. Carcinogenesis. 2021 Nov 12;42(11):1305–1313.
- Dong H, Zhou J, Cheng Y, et al. Biogenesis, functions, and role of CircRNAs in lung cancer. Cancer Manag Res. 2021;13:6651–6671.
- Li L, Zhang Q, Lian K. Circular RNA circ_0000284 plays an oncogenic role in the progression of non-small cell lung cancer through the miR-377-3p-mediated PD-L1 promotion. Cancer Cell Int. 2020;20:247.
- Zhu X, Han J, Lan H, et al. A novel circular RNA hsa_circRNA_103809/miR-377-3p/GOT1 pathway regulates cisplatin-resistance in non-small cell lung cancer (NSCLC). BMC Cancer. 2020 Dec 4;20(1):1190.
- Gao F, Wu H, Wang R, et al. MicroRNA-485-5p suppresses the proliferation, migration and invasion of small cell lung cancer cells by targeting flotillin-2. Bioengineered. 2019 Mar 5;10(1):1–12.
- Cheng H, Jiang W, Song Z, et al. Circular RNA circLPAR3 facilitates esophageal squamous cell carcinoma progression through upregulating HMGB1 via sponging miR-375/miR-433. Onco Targets Ther. 2020 Aug 4;13:7759.
- Guo F, Li S, Guo C, et al. Circular RNA circMAGI3 accelerates the glycolysis of non-small cell lung cancer through miR-515-5p/HDGF. Am J Transl Res. 2020 Jul 15;12(7):3953.
- Liu B, Sun X. miR-25 promotes invasion of human non-small cell lung cancer via CDH1. Bioengineered. 2019 Jul 6;10(1):271–281.
- Wang J, Zhu W, Tao G, et al. Circular RNA circ-LRP6 facilitates Myc-driven tumorigenesis in esophageal squamous cell cancer. Bioengineered. 2020 Aug 31;11(1):932–938.
- Chen H, Gu B, Zhao X, et al. Circular RNA hsa_circ_0007364 increases cervical cancer progression through activating methionine adenosyltransferase II alpha (MAT2A) expression by restraining microRNA-101-5p. Bioengineered. 2020 Nov 2;11(1):1269–1279.
- Bai S, Wu YY, Yan Y, et al. Construct a circRNA/miRNA/mRNA regulatory network to explore potential pathogenesis and therapy options of clear cell renal cell carcinoma. SCI REP. 2020 Aug 12;10(1):1–15.
- Xue YB, Ding MQ, Xue L, et al. CircAGFG1 sponges miR‐203 to promote EMT and metastasis of non-small-cell lung cancer by upregulating ZNF281 expression. Thorac Cancer. 2019 Jun 27;10(8):1692–1701.
- Zhang WY, Liu QH, Wang TJ, et al. CircZFR serves as a prognostic marker to promote bladder cancer progression by regulating miR-377/ZEB2 signaling. Biosci Rep. 2019 Dec 4;39(12):BSR20192779.
- Liang Z, Xu J, Ma Z, et al. MiR-187 suppresses non-small-cell lung cancer cell proliferation by targeting FGF9. Bioengineered. 2020 Dec 28;11(1):70–80.
- Sun Z, Zhang A, Hou M, et al. Circular RNA hsa_circ_0000034 promotes the progression of retinoblastoma via sponging microRNA-361-3p. Bioengineered. 2020 Sep 6;11(1):949–957.
- Ge C, Zeng B, Li R, et al. Knockdown of STIM1 expression inhibits non-small-cell lung cancer cell proliferation in vitro and in nude mouse xenografts. Bioengineered. 2019 Sep 28;10(1):425–436.
- Formosa A, Markert EK, Lena AM, et al. MicroRNAs, miR-154, miR-299-5p, miR-376a, miR-376c, miR-377, miR-381, miR-487b, miR-485-3p, miR-495 and miR-654-3p, mapped to the 14q32.31 locus, regulate proliferation, apoptosis, migration and invasion in metastatic prostate cancer cells. Oncogene. 2014 Oct 30;33(44):5173–5182.
- Wang Y, Li Y, He H, et al. Circular RNA circ-PRMT5 facilitates non-small cell lung cancer proliferation through upregulating EZH2 via sponging miR-377/382/498. Gene. 2019 Dec 15;720:144099.
- Yang B, Du K, Yang C, et al. CircPRMT5 circular RNA promotes proliferation of colorectal cancer through sponging miR-377 to induce E2F3 expression. J Cell Mol Med. 2020 Mar;24(6):3431–3437.
- Liang ZZ, Guo C, Zou MM, et al. circRNA-miRNA-mRNA regulatory network in human lung cancer: an update. Cancer Cell Int. 2020;20:173.
- Zhang HB, Qiu XM, Zhang YC, et al. Circ_0017639 facilitates proliferative, migratory, and invasive potential of non-small cell lung cancer (NSCLC) cells via PI3K/AKT signaling pathway. Bioengineered. 2022 Jan 8;13(1):1590–1601.
- Wang H, Tang Z, Duan J, et al. Cancer-released exosomal circular RNA circ_0008717 promotes cell tumorigenicity through microRNA-1287-5p/P21-activated kinase 2 (PAK2) axis in non-small cell lung cancer. Bioengineered. 2022 Mar 25;13(4):8937–8949.
- Du TT, Yi SN, Wang YY, et al. Circular RNA_0120376 regulates microRNA-148b-3 and centrosomal protein 55 to promote non-small cell lung cancer development. Bioengineered. 2022 May 13;13(5):11844–11855.
- Abdollahzadeh R, Daraei A, Mansoori Y, et al. Competing endogenous RNA (ceRNA) cross talk and language in ceRNA regulatory networks: a new look at hallmarks of breast cancer. J Cell Physiol. 2019 Jul;234(7):10080–10100.
- Shen B, Wang Z, Li Z, et al. Circular RNAs: an emerging landscape in tumor metastasis. Am J Cancer Res. 2019;9(4):630–643.
- Jishnu PV, Jayaram P, Shukla V, et al. Prognostic role of 14q32.31 miRNA cluster in various carcinomas: a systematic review and meta-analysis. Clin Exp Metastasis. 2020 Feb;37(1):31–46.
- Yu R, Cai L, Chi Y, et al. miR‑377 targets CUL4A and regulates metastatic capability in ovarian cancer. Int J Mol Med. 2018 Jun;41(6):3147–3156.
- Sompel K, Elango A, Smith AJ, et al. Cancer chemoprevention through frizzled receptors and EMT. Discov Oncol. 2021;12(1):32.
- Wang L, Shao J, Zhang X, et al. microRNA-377 suppresses the proliferation of human osteosarcoma MG-63 cells by targeting CDK6. Tumour Biol. 2015 May;36(5):3911–3917.
- Zhang J, Li Y, Dong M, et al. Long non-coding RNA NEAT1 regulates E2F3 expression by competitively binding to miR-377 in non-small cell lung cancer. Oncol Lett. 2017 Oct;14(4):4983–4988.
- Yao Q, Li Y, Pei Y, et al. Long non-coding RNA taurine up regulated 1 promotes osteosarcoma cell proliferation and invasion through upregulating Ezrin expression as a competing endogenous RNA of micro RNA-377-3p. Bioengineered. 2022 Jan 11;13(1):1767–1778.
- Raffaniello RD. Rab3 proteins and cancer: exit strategies. J Cell Biochem. 2021 Oct;122(10):1295–1301.
- Chang YC, Su CY, Chen MH, et al. Secretory RAB GTPase 3C modulates IL6-STAT3 pathway to promote colon cancer metastasis and is associated with poor prognosis. Mol Cancer. 2017 Aug 7;16(1):135.